Koers Suzhou Zelgen Biopharmaceuticals Co.,Ltd.
Aandelen
688266
CNE100003RP1
Farmaceutische producten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
46,12 CNY | -2,99% | -10,95% | -12,88% |
Omzet 2024 * | 1,02 mld. 140 mln. 132 mln. | Omzet 2025 * | 1,8 mld. 249 mln. 233 mln. | Marktkapitalisatie | 12,21 mld. 1,69 mld. 1,58 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -139 mln. -19,2 mln. -18,02 mln. | Nettowinst (verlies) 2025 * | 178 mln. 24,59 mln. 23,08 mln. | EV/omzet 2024 * | 12 x |
Nettoliquiditeiten 2024 * | - 0 0 | Nettoliquiditeiten 2025 * | - 0 0 | EV/omzet 2025 * | 6,78 x |
K/w-verhouding 2024 * |
-87,6
x | K/w-verhouding 2025 * |
68,5
x | Werknemers | 843 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 54,97% |
1 dag | -2,99% | ||
1 week | -10,95% | ||
Lopende maand | -14,43% | ||
1 maand | -12,72% | ||
3 maanden | -3,17% | ||
6 maanden | +6,81% | ||
Lopend jaar | -12,88% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Hui Ping Lu
FOU | Founder | 57 | 18-03-09 |
Ze Lin Sheng
CEO | Chief Executive Officer | 64 | 18-03-09 |
Gang Huang
DFI | Director of Finance/CFO | 53 | 01-01-19 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Bing Hui Zhang
BRD | Director/Board Member | 61 | - |
Ze Lin Sheng
CEO | Chief Executive Officer | 64 | 18-03-09 |
Hui Ping Lu
FOU | Founder | 57 | 18-03-09 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.00% | 34 M€ | +1,25% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
19-04-24 | 46,12 | -2,99% | 2 524 124 |
18-04-24 | 47,54 | -0,48% | 1 956 538 |
17-04-24 | 47,77 | -2,13% | 2 419 845 |
16-04-24 | 48,81 | -3,35% | 2 177 219 |
15-04-24 | 50,5 | -2,49% | 1 792 749 |
slotkoers Shanghai S.E., 19 april 2024
Meer koersenHerzieningen van WPA
Winst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-12,88% | 1,74 mld. | |
+24,60% | 672 mld. | |
+24,08% | 550 mld. | |
-5,63% | 351 mld. | |
+15,37% | 317 mld. | |
+7,38% | 292 mld. | |
+3,26% | 211 mld. | |
+0,78% | 203 mld. | |
-9,69% | 144 mld. | |
-6,63% | 141 mld. |